Singulair (montelukast) for asthma

March 1998

Merck is introducing Singulair (montelukast) for asthma.

It's a new leukotriene antagonist...similar to Accolate (zafirlukast).

Some leukotrienes are potent bronchoconstrictors. In fact they used to be called "slow-reacting substance of anaphylaxis."

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote